Patent: 10,167,492
✉ Email this page to a colleague
Summary for Patent: 10,167,492
| Title: | Process for manipulating the level of glycan content of a glycoprotein |
| Abstract: | The present invention provides a method for manipulating the fucosylated glycan content on a recombinant protein. |
| Inventor(s): | Daniel R. Leiske, Michael T. Trentalange |
| Assignee: | Amgen Inc |
| Application Number: | US15/529,950 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,167,492
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | PROLIA | denosumab | Injection | 125320 | June 01, 2010 | 10,167,492 | 2035-12-01 |
| Amgen Inc. | XGEVA | denosumab | Injection | 125320 | November 18, 2010 | 10,167,492 | 2035-12-01 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,167,492
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 202006002 | ⤷ Start Trial |
| South Africa | 201703729 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2016089919 | ⤷ Start Trial |
| United States of America | 2023159974 | ⤷ Start Trial |
| United States of America | 2021017565 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
